Hanlon, A L; Watkins Bruner, D; Peter, R et al. (2001) Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys 49:51-9
|
Hanlon, A L; Hanks, G E (2000) Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 46:559-66
|
Hanks, G E; Hanlon, A L; Pinover, W H et al. (2000) Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46:823-32
|
Hanlon, A L; Hanks, G E (2000) Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure. Cancer J 6 Suppl 2:S193-7
|
Hanks, G E; Hanlon, A L; Pinover, W H et al. (1999) Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 5:152-8
|
Hanks, G E (1999) Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncol 38 Suppl 13:69-74
|
Hanks, G E (1998) Strategies for improving the outcome of patients with poor prognosis prostate cancers. Acta Oncol 37:5-9;discussion 3
|
Hanlon, A L; Hanks, G E (1998) Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. Urology 52:735-8
|
Hanks, G E; Hanlon, A L; Schultheiss, T E et al. (1998) Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41:501-10
|
Hanlon, A L; Moore, D F; Hanks, G E (1998) Modeling postradiation prostate specific antigen level kinetics: predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma. Cancer 83:130-4
|
Showing the most recent 10 out of 23 publications